Neuroimaging is a medical discipline that uses non-invasive methods of visualizing the brain. In addition to being used to diagnose disease and assess brain health, neuroimaging is also valuable in the study of the brain, how the brain works, and how various activities impact the brain.

Feinstein Institute researchers are involved in a leading imaging research program in brain disease that is internationally recognized for developing novel imaging techniques to characterize and quantify brain patterns in neurodegenerative disorders. These include Parkinson’s disease, Huntington’s disease, dystonia and other neurological conditions. They use their findings for diagnosing disease and for assessing the extent of functional impairment as the disease progresses. Researchers are also investigating the regulation of key molecules to understand how brain chemistry relates to specific brain patterns and therapeutic outcome.

Feinstein Institute  investigators conducting neuroimaging research include David EidelbergJian Yi Li and Phoebe George Spetsieris.